European Archives - Page 162 of 997 - European Medical Journal

Increased Mortality Amongst Weekend Admissions

Weekend admission has been linked to higher mortality risk and post-procedure morbidity amongst patients entering hospital for transjugular intrahepatic portosystemic shunt.

Phone in someone's hand with medical imagery on it

From basic to bold: Introducing interactive medical education

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.

Fish Intake Linked to Juvenile Arthritis Risk: EULAR 2024 Findings

New data has linked the consumption of fish during pregnancy and the first year of life with juvenile idiopathic arthritis.

Novel Treatments for Systemic Sclerosis: EULAR 2024 Findings

EULAR has updated its recommendations for systemic sclerosis, incorporating four new therapies presented at its congress in 2024.

Biomedical Alliance in Europe: A Roundtable Discussion

Tune in to the latest EMJ Webinar, featuring three of the Biomedical Alliance in Europe’s most valued members, who join host Jonathan…

New MS blood test to launch in Europe

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.

AML Expert Exchange: Interactive Webinar

Watch this expert-led webinar on acute myeloid leukaemia (AML) maintenance therapy discussing clinical guidelines and evidence…

EuroPCR 2024 Interview: Julien Dreyfus

I began my residency in cardiology at Bichat Hospital in Paris, France. At that time, it was one of the leading institutions for valvular…

Fetal Origins of Paediatric Acute Myeloid Leukaemia

Researchers have uncovered crucial insights into the development of paediatric acute myeloid leukaemia, revealing that some cases may originate in the womb

Telehealth Equally Effective as In-Person Palliative Care for Advanced Lung Cancer Patients

A recent trial has shown that telehealth delivery of early palliative care is as effective as in-person visits for patients with advanced non-small cell lung cancer